Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...
A malaria vaccine with "world-changing" potential has been developed by scientists at the University of Oxford. The team expect it to be rolled out next year after trials showed up to 80% ...
A cheap malaria vaccine that can be produced on a massive scale has been recommended for use by the World Health Organization (WHO). The vaccine has been developed by the University of Oxford and ...
A "human challenge" study—purposefully infecting volunteers with malaria—has revealed crucial insights into how new, more ...
Each year malaria causes over 200 million disease episodes and 400,000 deaths, with an estimated two-thirds of those deaths being among children under the age of five. In a long-running effort ...
The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following ...
At the height of Obama mania, a significant announcement was made by the Kenya Medical Research Institute (Kemri) in the fight against malaria. On JulyI 24, drug and research company ...
The vaccine showed 49% to 57% efficacy among women who became pregnant after vaccination during a two-year trial period, providing “hope” for women who want to have a safe pregnancy from malaria.
2nd Malaria Vaccine: The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children. The recommendation follows advice from the WHO ...
Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots for other infectious diseases, and now plans to take malaria and tuberculosis ...
So, I was obviously ecstatic when the WHO announced its recommendation for widespread use of the first malaria vaccine on October 6, 2021. This RTS,S/AS01 (RTS,S) malaria vaccine is approved for ...
Several technological and scientific hurdles lie in the way of the ideal malaria vaccine development. They are mostly related to the very competent immune-evasion strategies developed by the parasite.